Paper42902436PubMed
Direction-specific biomarker profiles and clinical significance of plasma p-tau217/amyloid PET discordance in cognitively normal adults.
Huang Y and 7 others. Alzheimers Dement, 2026.
Cite this record
ConductScience Library. Direction-specific biomarker profiles and clinical significance of plasma p-tau217/amyloid PET discordance in cognitively normal adults. Papers, record 42902436. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42902436
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Direction-specific biomarker profiles and clinical significance of plasma p-tau217/amyloid PET discordance in cognitively normal adults.
- Journal
- Alzheimers Dement
- Year
- 2026
- Publication types
- Journal Article
- Revised in PubMed
- 2026-10-23
Source PubMed
Topics15
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| tau Proteins | Major topic |
| Positron-Emission Tomography | Major topic |
| Amyloid beta-Peptides | Major topic |
| Cognition | Major topic |
| Humans | |
| Female | |
| Male | |
| Biomarkers | |
| Cross-Sectional Studies | |
| Aged | |
| Alzheimer Disease | |
| Phosphorylation | |
| Aged, 80 and over | |
| Disease Progression | |
| Brain |
Source PubMed
Grants5
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| U19AG024904 | National Institute on Aging (NIA), National Institutes of Health (NIH) | U19AG024904 | PubMed | NIH RePORTER | |
| 2025ZD0215400 | National Science and Technology Major Project of China | PubMed | PubMed | ||
| 2022ZD0213800 | STI2030-Major Projects | PubMed | PubMed | ||
| 20250202 | Sjtu Trans-med Awards Research | PubMed | PubMed | ||
| 82171198 | National Natural Science Foundation of China | PubMed | PubMed |
References45
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 31009028 | Association Between Longitudinal Plasma Neurofilament Light and Neurodegeneration in Patients With Alzheimer Disease. | JAMA Neurol | 2019 | https://conductscience.org/library/papers/31009028 | PubMed |
| 2 | 26027810 | Auditory Verbal Learning Test is Superior to Rey-Osterrieth Complex Figure Memory for Predicting Mild Cognitive Impairment to Alzheimer's Disease. | Curr Alzheimer Res | 2015 | https://conductscience.org/library/papers/26027810 | PubMed |
| 3 | 3193141 | A Chinese version of the Mini-Mental State Examination; impact of illiteracy in a Shanghai dementia survey. | J Clin Epidemiol | 1988 | https://conductscience.org/library/papers/3193141 | PubMed |
| 4 | 41324928 | Plasma Phosphorylated Tau 217 and Amyloid Burden in Older Adults Without Cognitive Impairment: A Meta-Analysis. | JAMA Neurol | 2026 | https://conductscience.org/library/papers/41324928 | PubMed |
| 5 | 14590559 | Short forms of the Benton Judgment of Line Orientation Test: development and psychometric properties. | Arch Clin Neuropsychol | 2000 | https://conductscience.org/library/papers/14590559 | PubMed |
| 6 | 39021585 | Plasma p-tau217 concordance with amyloid PET among ethnically diverse older adults. | Alzheimers Dement (Amst) | 2024 | https://conductscience.org/library/papers/39021585 | PubMed |
| 7 | 37963289 | Modeling the temporal evolution of plasma p-tau in relation to amyloid beta and tau PET. | Alzheimers Dement | 2024 | https://conductscience.org/library/papers/37963289 | PubMed |
| 8 | 41627837 | Plasma Phosphorylated Tau 217 Cutoffs for Amyloid Pathology and Kidney Function, Body Mass Index, and Anemia. | JAMA Neurol | 2026 | https://conductscience.org/library/papers/41627837 | PubMed |
| 9 | 39030981 | Optimizing cutpoints for clinical interpretation of brain amyloid status using plasma p-tau217 immunoassays. | Alzheimers Dement | 2024 | https://conductscience.org/library/papers/39030981 | PubMed |
| 10 | 37118445 | Biomarker modeling of Alzheimer's disease using PET-based Braak staging. | Nat Aging | 2022 | https://conductscience.org/library/papers/37118445 | PubMed |
| 11 | 39068669 | Plasma Phosphorylated Tau 217 and Aβ42/40 to Predict Early Brain Aβ Accumulation in People Without Cognitive Impairment. | JAMA Neurol | 2024 | https://conductscience.org/library/papers/39068669 | PubMed |
| 12 | 27996103 | Validation of the Chinese Version of Montreal Cognitive Assessment Basic for Screening Mild Cognitive Impairment. | J Am Geriatr Soc | 2016 | https://conductscience.org/library/papers/27996103 | PubMed |
| 13 | 31157827 | Association of Amyloid and Tau With Cognition in Preclinical Alzheimer Disease: A Longitudinal Study. | JAMA Neurol | 2019 | https://conductscience.org/library/papers/31157827 | PubMed |
| 14 | 1573197 | Boston Naming Test: shortened versions for use in Alzheimer's disease. | J Gerontol | 1992 | https://conductscience.org/library/papers/1573197 | PubMed |
| 15 | 41322203 | Characterizing the onset and progression of Alzheimer's pathologies using amyloid and tau PET imaging and plasma p-tau217. | Brain Commun | 2025 | https://conductscience.org/library/papers/41322203 | PubMed |
| 16 | 36152307 | Confounding factors of Alzheimer's disease plasma biomarkers and their impact on clinical performance. | Alzheimers Dement | 2023 | https://conductscience.org/library/papers/36152307 | PubMed |
| 17 | 23437370 | The Shape Trail Test: application of a new variant of the Trail making test. | PLoS One | 2013 | https://conductscience.org/library/papers/23437370 | PubMed |
| 18 | 39044488 | Amyloid and Tau Prediction of Cognitive and Functional Decline in Unimpaired Older Individuals: Longitudinal Data from the A4 and LEARN Studies. | J Prev Alzheimers Dis | 2024 | https://conductscience.org/library/papers/39044488 | PubMed |
| 19 | 25443857 | The Centiloid Project: standardizing quantitative amyloid plaque estimation by PET. | Alzheimers Dement | 2015 | https://conductscience.org/library/papers/25443857 | PubMed |
| 20 | 42569234 | Parallel neuroinflammatory pathways to cerebrovascular burden and amyloid beta in Alzheimer's disease. | Alzheimers Dement (Amst) | 2026 | https://conductscience.org/library/papers/42569234 | PubMed |
Cited by1
The papers in our copy of PubMed whose reference list names this one, newest first.
| PMID | Title | Journal | Year | In Papers |
|---|---|---|---|---|
| 42902436 | Direction-specific biomarker profiles and clinical significance of plasma p-tau217/amyloid PET discordance in cognitively normal adults. | Alzheimers Dement | 2026 | https://conductscience.org/library/papers/42902436 |
Source PubMed
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/42902436
GET https://conductscience.org/api/papers/v1/42902436/references?page=2